Progress in Molecular Targeted Therapy for Thyroid Cancer: Vandetanib in Medullary Thyroid Cancer
Author:
Affiliation:
1. Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2011.37.8638
Reference26 articles.
1. Cancer statistics, 2011
2. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995
3. Thyroid Cancer Incidence Patterns in the United States by Histologic Type, 1992–2006
4. A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. RET Alterations Differentiate Molecular Profile of Medullary Thyroid Cancer;JCO Precision Oncology;2024-05
2. miR‐4443 targets TRIM14 to suppress metastasis and energy metabolism of papillary thyroid carcinoma (PTC) in vitro;Cell Biology International;2021-07-12
3. Thyrotoxicosis with concomitant thyroid cancer;Endocrine-Related Cancer;2019-07
4. Expression of GLUT1 in Neoplastic Cells of Papillary Thyroid Cancer;Turkish Journal of Oncology;2019
5. Aggressive Thyroid Gland Carcinoma: A Case Series;Archives of Otolaryngology and Rhinology;2017-12-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3